Advertisement
Screener

ROIVANT SCIENCES LTD. (ROIV) Net Margin

ROIVANT SCIENCES LTD. (ROIV) Net Margin

  • 2026-06-30: Net Margin -13164.84%.
  • 2026-03-31: Net Margin 12023.57%.
  • 2025-12-31: Net Margin -13301.20%.
  • 2025-09-30: Net Margin -7225.91%.

Complete source-backed net margin history.

Available history
2020-06-30 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-13164.84%
2026-03-3112023.57%
2025-12-31-13301.20%
2025-09-30-7225.91%
2025-06-30-10292.86%
2025-03-31-2727.54%
2024-12-311878.25%
2024-09-30-5143.78%
2024-06-301192.70%
2024-03-31-1675.33%
2023-12-3132747.62%
2023-09-30-8342.30%
2023-06-30-1349.50%
2023-03-311416.05%
2022-12-31-2064.36%
2022-09-30-2326.58%
2022-06-30-7682.54%
2022-03-31-2928.14%
2021-12-31-1168.96%
2021-09-30-1490.53%
2021-06-30-1062.48%
2021-03-31-3364.35%
2020-12-31-4539.63%
2020-09-30-2675.59%
2020-06-30-205.77%

Annual Net Margin

DateNet Margin
2026-03-31-3629.19%
2025-03-31-591.96%
2024-03-3113294.18%
2023-03-31-3200.22%
2022-03-31-1528.89%
2021-03-31-3400.86%

Similar stocks

Stock NameCountryMarket CapPE Ratio
INSMED Inc (INSM)United States$26.566B-26.60
Zoetis Inc. (ZTS)United States$29.045B11.38
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Viatris Inc (VTRS)United States$20.008B-0.00
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10